PLSE.RGT Rights Exercise

RIGHTS PULSE BIOSCIENCE (PLSE.RGT) announced a subscription rights offering. PLSE.RGT holders may exercise 1 right to purchase 0.10864186 Units at an estimated subscription price of USD 10.00 per share. Fractional shares will not be issued, but rather will be rounded down and a minimum of 10 Rights is required to receive a minimum of 1 whole Unit. Participants are advised to obtain the PROSPECTUS dated 04/06/2024 and related supplement for more details on the subscription price. Participants should consult their tax advisor for complete details in reference to withholding taxes.

Option (1): Take no action [Default option]

Option (2): EXERCISE RIGHTS - 1 right to purchase 0.10864186 Units at an estimated subscription price of USD 10.00 per Unit. And a minimum of 10 Rights is required to receive a minimum of 1 whole Unit.

The deadline to submit instructions for exercise will be 18/06/2024 16:00 (HONG KONG GMT+8).

Please fill in the following information and use the registered email address of Futu to send an email to cs@futuhk.com.

1. Account Number:
2. Name: (In Chinese or English)
3. Stock code: PLSE.RGT
4. Options: (1) or (2)
5. Number of shares participating in corporate actions:

Note to applicants:
1. For shareholders holding less than 10 shares of PLSE.RGT, they cannot participate in related corporate actions.
2. Option (1) is the default option. We will help clients to choose option (1) if have not received clients’ emails.
3. Once the relevant application is submitted, the stocks participating in the company's actions cannot be traded and the application cannot be withdrawn.
4. This corporate action does not accept additional applications, the maximum number of applications that a client can apply for does not exceed the number of eligible shares it holds.
5. The pending orders and unsettled shares will not be accepted for the time being.
6. Please confirm that the account funds are sufficient to pay the relevant fees of this corporate action. Otherwise, we will not bear any responsibility for the failure of your application.
7. If there is any update, all the information released by the listed company shall prevail.

Helpful？

Yes No